(S)-tert-butyl 1-(5-Fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propylcarbamate

Intermediate for Idelalisib. Idelalisib (trade name Zydelig) is a phosphoinositide 3-kinase inhibitor for the treatment of certain hematological malignancies. Idelalisib has been approved by the U.S Food and Drug Administration on July 23, 2014.


Product Name:                  (S)-tert-butyl 1-(5-Fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propylcarbamate

Synonyms:                         N/A

CAS Number:                     870281-85-9

Molecular Weight:            397.4483

Molecular Formula:          C22H24FN3O3

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               CC[C@@H](c1nc2cccc(c2c(=O)n1c1ccccc1)F)NC(=O)OC(C)(C)C

(S)-tert-butyl 1-(5-Fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propylcarbamate

  • $415.00
  • Ex Tax: $415.00

Available Options